At the time of writing, Metagenomi Inc [MGX] stock is trading at $2.77, down -6.73%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MGX shares have gain 6.13% over the last week, with a monthly amount drifted -30.92%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Metagenomi Inc [NASDAQ: MGX] stock has seen the most recent analyst activity on May 07, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, JP Morgan downgraded its rating to Neutral on May 02, 2024, and dropped its price target to $6. On March 05, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $25 on the stock. TD Cowen started tracking the stock assigning a Outperform rating. JP Morgan initiated its recommendation with a Overweight and recommended $16 as its price target on March 05, 2024. Jefferies started tracking with a Buy rating for this stock on March 05, 2024, and assigned it a price target of $23. In a note dated March 05, 2024, Chardan Capital Markets initiated an Buy rating and provided a target price of $21 on this stock.
For the past year, the stock price of Metagenomi Inc fluctuated between $1.61 and $12.74. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Metagenomi Inc [NASDAQ: MGX] shares were valued at $2.77 at the most recent close of the market. An investor can expect a potential return of 152.71% based on the average MGX price forecast.
Analyzing the MGX fundamentals
According to Metagenomi Inc [NASDAQ:MGX], the company’s sales were 55.08M for trailing twelve months, which represents an -6.87% plunge. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -1.61%, Pretax Profit Margin comes in at -1.37%, and Net Profit Margin reading is -1.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.44 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.65 points at the first support level, and at 2.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.94, and for the 2nd resistance point, it is at 3.10.
Ratios To Look Out For
It is important to note that Metagenomi Inc [NASDAQ:MGX] has a current ratio of 6.18. As well, the Quick Ratio is 6.18, while the Cash Ratio is 0.55. Considering the valuation of this stock, the price to sales ratio is 1.88, the price to book ratio is 0.41.
Transactions by insiders
Recent insider trading involved Wapnick Pamela, Chief Financial Officer, that happened on Dec 05 ’24 when 1559.0 shares were sold. Chief Financial Officer, Wapnick Pamela completed a deal on Sep 05 ’24 to sell 6265.0 shares. Meanwhile, 10% Owner Novo Holdings A/S bought 0.8 million shares on Feb 13 ’24.
